{
  "abstract": "Objective To explore patient experiences with the RELEASE (Redressing long-term antidepressant use) toolkit resources, including antidepressant hyperbolic tapering plans designed to minimise withdrawal symptoms as part of the RELEASE trial’s implementation evaluation to understand what aspects of the toolkit work well and identify areas where refinement could enhance future implementation. The RELEASE intervention, a multistrategy intervention codesigned with general practitioners (GPs) and patients to prompt and support stopping long-term (>12 months) antidepressants, is being evaluated in an effectiveness-implementation hybrid type-1 cluster randomised controlled trial in general practice.Study design One-to-one semistructured qualitative interviews using reflexive thematic analysis to identify patterns of shared meaning.Setting General practice, south-east Queensland, Australia.Participants Adult participants (aged 18 years or older) taking an antidepressant long-term allocated to the intervention arm of the RELEASE trial.Results 31 participants with an average duration of antidepressant use of 16.5 years (range 1–30 years) were interviewed. Seven themes were identified. Across seven themes, participants described how the RELEASE toolkit resources prompted reflection on their antidepressant use, supported informed conversations with GPs, and offered tapering plans that were both structured enough to instil confidence and flexible enough to help participants feel in control of their tapering journey. They also identified barriers, including beliefs that very small tapering doses were unnecessary, difficulty accessing the mini-doses required for hyperbolic tapering and the challenge of managing withdrawal symptoms. For those who successfully stopped, the transition was associated with a renewed sense of autonomy. Participants also offered practical suggestions to strengthen the toolkit and its broader implementation.Conclusions The RELEASE toolkit resources played a meaningful role in prompting and supporting informed shared decision-making and guiding attempts to stop antidepressants. Clearer messaging about the potential for withdrawal symptoms and access to mini-doses for tapering are needed to support patients to safely stop antidepressants.Trial registration number ACTRN12622001379707p; Pre-results.",
  "authors": [
    {
      "affiliations": [
        "The University of Queensland, Brisbane, Queensland, Australia"
      ],
      "name": "Polyana Moura Ferreira"
    },
    {
      "affiliations": [
        "The University of Queensland, Brisbane, Queensland, Australia"
      ],
      "name": "Suzanne McDonald"
    },
    {
      "affiliations": [
        "The University of Queensland, Brisbane, Queensland, Australia"
      ],
      "name": "Katharine A Wallis"
    },
    {
      "affiliations": [
        "The University of Queensland, Brisbane, Queensland, Australia"
      ],
      "name": "Maria Donald"
    }
  ],
  "title": "Toolkit to prompt and support stopping antidepressants in general practice: an interview study exploring patient participants’ experiences in the RELEASE trial",
  "uid": "21f5c51c-27b3-50dd-9962-c6c65c4b4dbe"
}